BBSRC Portfolio Analyser
Award details
An E. coli genetic screen for factors that modify DNA methylation
Reference
BBS/E/B/0000Q153
Principal Investigator / Supervisor
Professor Wolf Reik
Co-Investigators /
Co-Supervisors
Institution
Babraham Institute
Department
Babraham Institute Department
Funding type
Research
Value (£)
11,605
Status
Completed
Type
Institute Project
Start date
08/08/2005
End date
07/08/2007
Duration
24 months
Abstract
Work with stem cells promises new and exciting applications in regenerative medicine. Somatic cells might be taken directly from patients, and their nuclei reprogrammed to a stem cell (pluripotent) state by somatic cell nuclear transfer (SCNT) into oocytes. This scenario is difficult, however, because of inefficient epigenetic reprogramming during SCNT, and because of ethical difficulties with obtaining oocytes for this purpose. It is therefore important to begin to identify `reprogramming factors¿ that is molecules or enzymes that are able to revert epigenetic modifications in somatic cells to those in stem cells.
Summary
unavailable
Committee
Closed Committee - Genes & Developmental Biology (GDB)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search